174397-60-5Relevant academic research and scientific papers
Compositions and methods of inhibiting the binding of E-selectin or P-selectin or sialyl-Lewisx or sialyl-Lewisa
-
, (2008/06/13)
This invention relates to compounds that inhibit the binding of E-selectin or P-selectin to sialyl-Lewisx or sialyl-Lewisa presented on a cell surface having the general structure: STR1 This invention also relates to methods of inhibiting the binding of E-selectin or P-selectin to sialyl-Lewisx or sialyl-Lewisa presented on a cell surface using said compounds and to pharmaceutically active compositions comprising compounds that inhibit the binding of E-selectin to sialyl-Lewisx and to methods of treatment of septic shock, ARDS, Crohn's disease, chronic inflammatory diseases, such as psoriasis and rheumatoid arthritis, and reperfusion injuries that occurs following heart attacks, strokes and organ transplants and to the treatment of cancer.
